Key Highlights
- Millie raises $12M Series A, co-led by TMV and Foreground Capital, with support from Pivotal Ventures and the March of Dimes Innovation Fund.
- New clinics launching in 2025, starting in San Jose, CA, in partnership with Good Samaritan Hospital (HCA Healthcare).
- Millie’s midwifery-led model delivers 30% better NTSV C-section rates and 67% better preterm birth rates than national averages.
- Expanding gynecology and wraparound services beyond maternity care, including mental health counseling, lactation support, and relationship therapy.
- AI-driven care platform enhances remote patient monitoring and clinical efficiency.
Source: Business Wire
Notable Quotes
- “We believe Millie has built the ideal model to drive better outcomes: midwifery-led, powered by both clinician and patient-facing technology, in partnership with health systems and payers.” — Emma Silverman, Partner at TMV
- “We are proud to back this visionary founding team to fill these gaps and set a new standard of care for the 6 million pregnancies each year.” — Dr. Alice Zheng, Partner at Foreground Capital
- “Millie’s inclusive approach, focus on overlooked markets, broad-based health system partnership strategy, and in-network care is purpose-built to address critical access gaps in maternity care.” — Erin Harkless Moore, Managing Director, Investments at Pivotal Ventures
- “Our community deserves exceptional, compassionate care, and Millie is bringing just that to Good Samaritan Hospital.” — Patrick Rohan, CEO at Good Samaritan Hospital
Why This Matters
Maternity care in the U.S. is in crisis, with high costs, declining access, and worsening outcomes. Over 35% of counties lack maternity care, and traditional OB-GYN models struggle to meet growing needs. Millie’s midwifery-led, technology-driven approach offers a scalable solution with proven clinical results. Backed by leading women-focused investors, Millie is poised to redefine maternal care, improving outcomes for historically underserved communities while expanding its reach in 2025.
